For more Clinical Practice Guidelines, please go to Guidelines.0 References Medscape © 2022 WebMD, LLC Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape. Cite this: Ovarian Cancer Clinical Practice Guidelines (NCCN, 2022) - Med...
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to platinum-based chemotherapy. However, the majority of patients relapse following initial surgery and chemotherapy, highlighting the
NCCN Updates Ovarian Cancer GuidelinesAnis unavailable. This article is available as HTML full text and PDF.doi:10.1097/01.COT.0000397191.46574.8bSusmanEdOncology Times
Ovarian cancer is a formidable disease characterized by the abnormal growth of cells in the ovaries, often presenting with subtle or nonspecific symptoms in its early stages, leading to challenges in early detection. As one of the deadliest gynecological malignancies, ovarian cancer is typically diagno...
CE NCCN GUIDELINES® INSIGHTS Ovarian Cancer, Version 1.2019 NCCN: Continuing Education Target Audience: This activity is designed to meet the educational needs All clinicians completing this activity will be issued a certificate of par- of physicians, nurses, pharmacists, and other healthcare pro...
Breast cancer, version 1.2016 featured updates to the NCCN guidelines Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall managem... WJ Gradishar,BO Anderson,R Balassanian,... 被引量: 6发表:...
The NCCN also has broader guidelines with eligibility criteria for HBOC testing. Their recommendations are summarized in Table 4.1 The outcomes of genetic counselling are complex and require detailed and OVARIAN/TUBAL/PERITONEAL CARCINOMA SCREENING While excellent screening options for breast cancer in ...
Ovarian cancer patients who receive care that coincides with the National Comprehensive Cancer Network (NCCN) guidelines may have an increased chance of survival, according to the results of a recent study published in the July 2013 issue of Gynecologic Oncology. The study enrolled 13,321 patients ...
In order to evaluate the risk of cardiovascular mortality in patients with ovarian cancer, we included influencing factors including age, histological type, surgical method, chemotherapy, whether distant metastasis, race and developed a nomogram to evaluate the ability to predict occurrence. At present,...
According to 2022 NCCN clinical practice guidelines to ovarian cancer, PARPi's maintenance treatment princi- ples and time points are as follows(Fig. 3). With the popularization and application of PARP inhib- itors in the clinic, especially in the treatment of ovarian cancer, the problem ...